What is the level of liabilities of InBioGen Co this year?
InBioGen Co has a debt balance of 2.62 B KRW this year.
InBioGen Co Liabilities 2024
InBioGen Co Liabilities
2.62 B KRW
Ticker
101140.KS
ISIN
KR7101140002
In 2024, InBioGen Co's total liabilities amounted to 2.62 B KRW, a -92.99% difference from the 37.4 B KRW total liabilities in the previous year.
InBioGen Co Aktienanalyse
What does InBioGen Co do?
InBioGen Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing InBioGen Co's Liabilities
InBioGen Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating InBioGen Co's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing InBioGen Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
InBioGen Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in InBioGen Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about InBioGen Co stock
What were the liabilities of InBioGen Co compared to the previous year?
The liabilities of InBioGen Co have increased by -92.99% dropped compared to the previous year.
What are the consequences of high debt for investors of InBioGen Co?
High liabilities can pose a risk for investors of InBioGen Co, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in InBioGen Co?
Low liabilities mean that InBioGen Co has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of InBioGen Co affect the company?
An increase in liabilities of InBioGen Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of InBioGen Co affect the company?
A decrease in the liabilities of InBioGen Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of InBioGen Co?
Some factors that can influence the liabilities of InBioGen Co include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of InBioGen Co so important for investors?
The liabilities of InBioGen Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can InBioGen Co take to modify the liabilities?
To change its liabilities, InBioGen Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does InBioGen Co pay?
Over the past 12 months, InBioGen Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, InBioGen Co is expected to pay a dividend of 0 KRW.
What is the dividend yield of InBioGen Co?
The current dividend yield of InBioGen Co is .
When does InBioGen Co pay dividends?
InBioGen Co pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of InBioGen Co?
InBioGen Co paid dividends every year for the past 0 years.
What is the dividend of InBioGen Co?
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
In which sector is InBioGen Co located?
InBioGen Co is assigned to the 'Cyclical consumption' sector.
Wann musste ich die Aktien von InBioGen Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of InBioGen Co from 11/14/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 11/14/2024.
When did InBioGen Co pay the last dividend?
The last dividend was paid out on 11/14/2024.
What was the dividend of InBioGen Co in the year 2023?
In the year 2023, InBioGen Co distributed 0 KRW as dividends.
In which currency does InBioGen Co pay out the dividend?
The dividends of InBioGen Co are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von InBioGen Co
Our stock analysis for InBioGen Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of InBioGen Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.